Login / Signup
Assessments of the utilities of CSF NPTX2 for disease progression in cognitively normal individuals who progress to clinical MCI and AD.
Leslie M Shaw
Douglas Galasko
Published in:
Annals of neurology (2023)
Keyphrases
</>
mild cognitive impairment
cognitive decline
cerebrospinal fluid